Balyasny Asset Management
LAB icon

Balyasny Asset Management’s Standard BioTools LAB Stock Holding History

Balyasny Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-86,005
Closed -$112K – 3342
2025
Q3 		$112K Hold
86,005
– – ﹤0.01% 2780
2025
Q2 		$103K Hold
86,005
– – ﹤0.01% 2686
2025
Q1 		$92.9K Sell
86,005
-648,999
-88% -$911K ﹤0.01% 2688
2024
Q4 		$1.29M Sell
735,004
-256,700
-26% -$478K ﹤0.01% 1846
2024
Q3 		$1.91M Sell
991,704
-6,458
-0.6% -$12.6K ﹤0.01% 1686
2024
Q2 		$1.77M Sell
998,162
-3,846,889
-79% -$9.4M ﹤0.01% 1578
2024
Q1 		$13.1M Buy
4,845,051
+2,662,864
+122% +$6.43M 0.02% 813
2023
Q4 		$4.82M Sell
2,182,187
-514,523
-19% -$1.1M 0.01% 1124
2023
Q3 		$7.82M Buy
2,696,710
+595,020
+28% +$1.56M 0.02% 935
2023
Q2 		$4.06M Buy
+2,101,690
New +$4.15M 0.01% 1133
2022
Q3 		– Sell
-1,137,361
Closed -$1.82M – 3065
2022
Q2 		$1.82M Buy
+1,137,361
New +$2.81M 0.01% 1468
2022
Q1 		– Sell
-700,000
Closed -$2.74M – 2666
2021
Q4 		$2.74M Buy
700,000
+381,009
+119% +$1.78M 0.01% 1090
2021
Q3 		$2.1M Buy
+318,991
New +$2.1M 0.01% 1112
2018
Q2 		– Sell
-25,488
Closed -$149K – 1982
2018
Q1 		$149K Buy
25,488
+14,388
+130% +$94.5K ﹤0.01% 1798
2017
Q4 		$65K Buy
+11,100
New +$60.8K ﹤0.01% 2000

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Balyasny Asset Management's LAB Position: Q4 2025 in Review

Balyasny Asset Management sold out of Standard BioTools (LAB) in Q4 2025, closing a stake of 86,005 shares — an estimated $112K sold.

Balyasny Asset Management first reported a position in LAB in Q4 2017 and held it in 15 quarters. The position peaked at $13.1M in Q1 2024. 159 funds tracked by Wall St. Rank hold LAB as of Q4 2025.

  • Balyasny Asset Management reported no remaining Standard BioTools position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 86,005 Standard BioTools shares in Q4 2025, an estimated $112K.
  • Balyasny Asset Management first reported a position in Standard BioTools in Q4 2017 and held it in 15 quarters.
  • Balyasny Asset Management's Standard BioTools position peaked at $13.1M in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.